CHAPERONE THERAPEUTICS, INC.
CHAPEL HILL, NC · CIK 0001694381 · Biotech · Defunct
Small molecule inhibitors of protein kinase CK2 to restore Heat Shock Transcription Factor 1 (HSF1) levels and reduce protein misfolding in neurodegenerative diseases
chaperonetherapeutics.com →- Grants
- $4.9M
- 4 awards
- Sector median: 1
- Raised
- $457K
- 1 Form D · Jan 2017
- 117 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 4
- 3 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2016201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Drug Activation of HSF1 for Prevention of Noise-Induced Hearing Loss | $269,999 | |
| Private capital raised | Form D · SEC | $456,569 | |
| Federal grant | Department of Health and Human Services · Phase II · Discovering a Disease Modifying Therapeutic to Treat Huntington's Disease | $2,974,518 | |
| Federal grant | Department of Health and Human Services · Phase II · Discovering a Disease Modifying Therapeutic to Treat Huntington's Disease | $1,300,009 | |
| Federal grant | Department of Health and Human Services · Phase II · Discovering a Disease Modifying Therapeutic to Treat Huntington's Disease | $374,500 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2601 | NEURODON, LLC | — | $500K |
| 2602 | JumpStart Fertility, Inc. | — | $500K |
| 2603 | ENFUEGO THERAPEUTICS, INC. | — | $500K |
| 2604 | CHAPERONE THERAPEUTICS, INC. | — | $457K |
| 2605 | CONCARLO HOLDINGS, LLC | — | $450K |
| 2606 | GSNO THERAPEUTICS, INC. | — | — |
| 2607 | ANEURYST, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Kalpana MerchantExecutive Officer
- Maria Sippola-ThieleDirector · Executive Officer · Promoter
- Dennis ThieleDirector · Executive Officer
Patents
- Substituted Pyrazoles As Heat Shock Transcription Factor Activatorsgranted
- Substituted Pyrazoles As Heat Shock Transcription Factor Activatorsgranted
- Substituted 1,3-THIAZOLES As Heat Shock Transcription Factor 1 Activatorsgranted
- Compositions And Methods Relating To Heat Shock Transcription Factor Activating Compounds And Targets Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.